Bristol-Myers shopping $100 mil DTC media work

Published on .

Bristol-Myers Squibb Co. has put its estimated $80 million to $100 million direct-to-consumer prescription drug media business up for review. The bulk of spending has been for the $66.5 million Pravachol cholesterol-reduction brand but also includes Buspar anxiety and Zerit HIV treatments. Western International Media, West Hollywood, Calif., is the incumbent.

Copyright November 1998, Crain Communications Inc.

Most Popular
In this article: